English Global
Dr. Rajesh Jain has more than 42 years of experience in the pharmaceutical and biological space. He has been granted over 50 patents in the field of vaccines, pharmaceuticals, and novel technologies. He was among the Top 40 Global most influential persons as per the list put together by an internationally reputed organization, World Pharmaceutical Frontiers, published in SPG Media, London. He is the current Chairman of the Confederation of Indian Industry (CII) Committee for Biotechnology, Chairman of Life Sciences Sector Skill Development Council (LSSSDC), serves as Chairman for Scientific Advisor Committee (SAC) of Center of Innovative and Applied Bioprocess (CIAB). He is on the Board of Governors at National Institute of Pharmaceutical Education and Research (NIPER). Dr. Rajesh Jain’s commitment and actions towards making affordable vaccines is demonstrated at the GAVI Pledge Conferences in June 2011 and in January 2015 wherein Panacea Biotec pledged to maintain lower prices irrespective of the geopolitical crises and inflationary environment at that time. He is also Managing Director of the Company’s wholly owned subsidiary, Panacea Biotec Pharma Limited and holds directorship in PanEra Biotec Private Limited and Adveta Power Private Limited.
Panacea Biotec is not just a company to me - it’s a mission, a legacy, and a responsibility. I have seen it evolve from my father and elder brother’s vision into a global innovation-driven healthcare company that saves, improves lives and puts smiles on people’s faces every day. My interest stems from the impact we create and advancing research into unmet medical needs - whether it’s developing next-generation vaccines or, affordable complex generics.
What drives me is knowing that work at Panacea Biotec isn’t theoretical - it reaches children who truly need affordable vaccines and patients who need access to complex and affordable therapies. We have built something that balances science, purpose, and scale. I am passionate as we’re solving real problems with ingenuity and integrity. The future of global health needs bold, trusted players, and our journey is far from over.